Increased mitochondrial DNA copy-number in CEM cells resistant to delayed toxicity of 2',3'-dideoxycytidine

Biochemical Pharmacology
Mia BjerkeAnna Karlsson

Abstract

The nucleoside analog 2',3'-dideoxycytidine (ddC) has been used for treatment of human immunodeficiency virus (HIV) infections. ddC causes delayed toxicity when cells are exposed to the drug at low concentration for prolonged periods of time. The delayed toxicity is due to inhibition of mitochondrial DNA (mtDNA) replication, which results in mtDNA depletion and mitochondrial dysfunction. In the present study we have cultured CEM T-lymphoblast cells in the presence of low concentrations of ddC to generate two cell lines resistant to the delayed toxicity of the drug. Both cell lines were resistant to mtDNA depletion by ddC. The mechanism of ddC resistance was investigated and we showed that the resistant cells had decreased mRNA expression of the nucleoside kinases deoxycytidine kinase and thymidine kinase 2. We also studied the mitochondrial DNA in the cells and showed that the ddC-resistant cells had structurally intact mtDNA but 1.5-2-fold increased mtDNA copy-number as well as increased levels of the mitochondrial transcription factor A (Tfam). Our study suggests that cells may increase their level of mtDNA to counteract mtDNA depletion induced by ddC, while keeping pronounced antiviral activity of the drug.

References

Nov 15, 1995·The Biochemical Journal·M MagnaniL Chiarantini
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J J SongB S Mitchell
Jun 27, 1997·The Journal of Biological Chemistry·V BianchiP Reichard
Jun 13, 1998·The Journal of Biological Chemistry·B SchneiderD Deville-Bonne
Oct 27, 1999·Biochemical Pharmacology·R P AgarwalM Fernandez
Dec 10, 1999·The Biochemical Journal·L RossiM Magnani
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·V DolceJ E Walker
Aug 30, 2001·The Journal of Biological Chemistry·A A JohnsonK A Johnson
Oct 23, 2001·Mammalian Genome : Official Journal of the International Mammalian Genome Society·A RantanenN G Larsson
Mar 15, 2002·The New England Journal of Medicine·Hélène C F CôtéJulio S G Montaner
Jul 19, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Caroline PetitJacques Leibowitch
Mar 16, 2004·Human Molecular Genetics·Mats I EkstrandNils-Göran Larsson
May 28, 2004·Nature·Aleksandra TrifunovicNils-Göran Larsson
Sep 29, 2006·The Journal of Biological Chemistry·Harold R Lee, Kenneth A Johnson
Oct 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Marjorie J LindhurstLeslie G Biesecker
Mar 9, 2007·Cancer Metastasis Reviews·Jing ZhangCarol E Cass

❮ Previous
Next ❯

Citations

Oct 23, 2012·Mitochondrion·Afshan N Malik, Anna Czajka
Nov 27, 2019·Antimicrobial Agents and Chemotherapy·Zachary M SticherAlexander A Kolykhalov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.